Aplastic Anemia expert, Dr. David Margolis from Children’s Hospital of Wisconsin and PNH expert Dr. Thomas Deloughery from Oregon Health & Science University discuss research of most relevance to patients reported over the past year on the biology and treatment on aplastic anemia and PNH. These studies were presented at the American Society of Hematology (ASH) 2017 meeting in Atlanta, GA. Research findings are explained along with the potential impact of this research on understanding and treating aplastic anemia and PNH.
Dr. David Araten is an assistant professor in the Division of Hematology at the NYU School of Medicine in New York City. Dr. Araten’s research has focused largely on paroxysmal nocturnal hemoglobinuria and he has published in a wide variety of peer reviewed journals on this topic.
Dr. Parker uses a number of real life case studies to help you understand PNH and its treatment. During this program, he explains PNH, discusses the possible causes and defines symptoms you might experience. He also covers treatment options, including eculizumab, immunosuppressive drug therapy, stem cell transplantation, and supportive therapies like blood transfusions.